Acta Naturae
Scope & Guideline
Driving Innovation in Life Sciences Research
Introduction
Aims and Scopes
- Molecular Biology and Genetics:
The journal publishes research on molecular mechanisms, genetic variations, and gene expression regulation, with a particular emphasis on novel genetic tools and methodologies. - Biotechnology and Bioengineering:
Research articles often explore innovative applications of biotechnology, including synthetic biology, recombinant DNA technology, and the development of therapeutic agents. - Cancer Research and Therapeutics:
A significant portion of the journal's content is dedicated to cancer biology, focusing on tumor microenvironments, signaling pathways, and potential therapeutic strategies. - Immunology and Infectious Diseases:
The journal covers topics related to immune responses, vaccine development, and the mechanisms of infectious diseases, particularly in the context of emerging viral pathogens. - Cell Biology and Physiology:
Research on cellular mechanisms, including autophagy, cell signaling, and the physiological role of cells in various contexts, is a core area of focus. - Nanotechnology in Medicine:
The journal features studies on the application of nanotechnology in biomedical research, including drug delivery systems and diagnostic tools. - Neuroscience and Neurobiology:
Acta Naturae includes research on neurological disorders, neuronal signaling, and the impact of genetic factors on brain function.
Trending and Emerging
- CRISPR and Genome Editing Technologies:
There's a growing interest in CRISPR and other genome editing technologies, reflecting their transformative potential in genetics and therapeutic applications. - Personalized Medicine and Genomics:
Emerging studies focus on personalized medicine approaches, particularly in cancer treatment and genetic disorders, emphasizing the need for tailored therapeutic strategies. - Nanomedicine and Drug Delivery Systems:
Research on nanotechnology applications in medicine, especially for targeted drug delivery and enhanced diagnostic techniques, is gaining momentum. - Synthetic Biology and Bioengineering:
The rise of synthetic biology as a field is evident, with increasing publications on engineered biological systems and their applications in biotechnology. - Neurobiology of Disease:
An increased focus on the molecular and cellular mechanisms underlying neurodegenerative diseases indicates a trend towards understanding the complexities of brain health. - Immunotherapy and Cancer Vaccines:
Research is increasingly directed towards innovative immunotherapeutic approaches, including cancer vaccines and monoclonal antibodies, reflecting advancements in cancer treatment.
Declining or Waning
- Classical Pharmacology:
There has been a noticeable decrease in studies focused solely on classical pharmacological approaches, with a shift towards more integrated and innovative methodologies in drug discovery. - Basic Virology Studies:
Research strictly limited to basic virology without a translational or therapeutic angle has become less frequent, as the interest shifts towards practical applications in vaccine and antiviral development. - Traditional Genetic Mapping Techniques:
The focus on classical genetic mapping techniques has diminished, likely due to the increasing prevalence of high-throughput sequencing technologies and advanced genetic editing tools. - In vitro Models of Disease:
While still relevant, there is a decline in the number of papers utilizing traditional in vitro models of disease, as more researchers favor complex in vivo systems and organ-on-chip technologies. - Environmental and Ecological Studies:
Research focusing on environmental impacts and ecological genetics has seen a decline, possibly overshadowed by the increasing emphasis on biomedical applications.
Similar Journals
FASEB BioAdvances
Advancing Knowledge in Biochemistry and BeyondFASEB BioAdvances, published by WILEY, is an esteemed open-access journal dedicated to advancing the fields of biochemistry, molecular biology, and physiology. Since its inception in 2019, the journal has rapidly established a significant presence within the academic community, boasting an impressive impact factor reflective of its Q2 and Q3 standings across various categories, including Biochemistry, Genetics and Molecular Biology, Cancer Research, Molecular Medicine, and Physiology. The journal aims to disseminate high-quality research and innovative findings to enhance the understanding of biological processes, making it a vital resource for researchers, professionals, and students alike. With its commitment to open access, FASEB BioAdvances ensures that groundbreaking research is available to a global audience, facilitating collaboration and exploration in these rapidly evolving scientific domains.
Cell Reports Medicine
Exploring the nexus of biochemistry and clinical practice.Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.
FOLIA BIOLOGICA
Connecting Researchers to Transformative IdeasFOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.
Cell Reports
Connecting Scientists to Transformative DiscoveriesCell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.
Cell and Bioscience
Fostering Innovation in Biochemistry and GeneticsCell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.
FEBS Journal
Connecting Researchers to Transformative DiscoveriesFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
BIOCELL
Innovative Insights into Cellular MechanismsBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
Life Science Alliance
Innovating Open Access for Global Impact.Life Science Alliance, published by LIFE SCIENCE ALLIANCE LLC, is a premier open access journal that has been making significant contributions to the fields of Biochemistry, Genetics and Molecular Biology, Ecology, Health, Toxicology and Mutagenesis, and Plant Science since its inception in 2018. With an impressive ranking in Scopus, including Q1 quartile positions and high percentiles in relevant categories, this journal is a vital resource for researchers, professionals, and students alike who seek to advance knowledge and innovation in life sciences. The journal operates on an open access model, ensuring that research findings are freely available to the global scientific community, thereby enhancing the visibility and impact of published work. With a commitment to fostering collaboration and disseminating high-quality research, Life Science Alliance serves as an essential platform for the promotion and exchange of scientific knowledge, aiming to bridge gaps and stimulate discussions across multiple disciplines.
Journal of Biological Engineering
Transforming Ideas into Impactful DiscoveriesJournal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.
FEBS Open Bio
Connecting researchers to the pulse of biochemical advancements.FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.